Next Questions: Aggressive B-Cell Lymphoma
By Greg Nowakowski, MD - Last Updated: November 14, 2022At the 2021 Society of Hematologic Oncology Annual Meeting, Greg Nowakowski, MD, of Mayo Clinic Rochester, discussed what to expect going forward in the field of aggressive B-cell lymphoma.
Advertisement
Post Tags:SOHO21
Advertisement
Related Posts
LucyRx’s pharmacy network includes Northwestern Medicine Specialty Pharmacy, Dana Farber Cancer Institute, and more..
Dr. Locke is a lead investigator of the ZUMA-1 and ZUMA-7 trials, which led to the FDA approval of axi-cel.
Efficacy and safety profile data were presented at the AACR Annual Meeting 2025.
The ASCO Association Board Chair has written letters to the new heads of the CMS, FDA, and NIH.
Sairah Ahmed, MD, tells about current management challenges and promising developments in treatment options.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.